Event Overview

The immune system normally identifies and eliminates cancer cells prior to tumor formation. However, cancer cells can induce inhibitory mechanisms that limit antitumor immune activity, allowing for disease progression. In this webinar brought to you by The Scientist and Bio-Techne, Dario Vignali and Peter Westcott will discuss the tug-of-war between cancer cells and the immune system, how cancer cells evade immune cells, and what can be done to circumvent or attenuate these mechanisms for therapeutic purposes.

Topics to be covered

  • Understanding immune inhibitory mechanisms in cancer
  • Modeling T-cell dysfunction in colon cancer

  • Monday, January 10, 2022
    2:30 - 4:00 PM Eastern Time 

    Meet the speakers

    Dario A. Vignali, PhD
    Frank Dixon Chair in Cancer Immunology
    Vice Chair and Distinguished Professor of Immunology
    Director, Cancer Immunology Training Program
    Department of Immunology, School of Medicine
    University of Pittsburgh

    Peter Westcott, PhD
    Postdoctoral Scientist
    David H. Koch Institute for Integrative Cancer Research
    Massachusetts Institute of Technology

    Sponsored by



    TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220

    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.